The Shotlee Journal
Expert insights on GLP-1 medications, peptide therapy, and evidence-based approaches to weight management.
Loading articles...
Showing 9 / 1263 articles
American Made GLP-1 has crowned CoreAge Rx as the best GLP-1 provider for 2026, earning a stellar 4.9 out of 5 rating after reviewing over 10 U.S. telehealth platforms. The 'Editor's Choice' award highlights its FDA-approved semaglutide and tirzepatide programs with board-certified physician oversight. Patients report 10-26% body weight loss in 12 months with personalized care.
An independent review by GLP-1 Planet has crowned CoreAge Rx as the top GLP-1 provider out of 78 evaluated, with a standout 9.6/10 rating driven by its $99/month flat pricing. This includes virtual consultations, medications like semaglutide and tirzepatide, ongoing support, and direct delivery. Patients benefit from transparent, comprehensive weight management care.
American Girl Dolls have undergone a controversial 'Ozempic' makeover, with slimmer bodies aimed at the 'modern era'—but many parents and influencers are far from impressed. The redesign highlights the cultural impact of GLP-1 medications like Ozempic on body ideals. Explore the debate, drug mechanisms, and health considerations.
Food noise isn't just hunger—it's exhausting mental commentary on dieting, body image, and worthiness shaped by culture. While Ozempic and GLP-1 agonists like Wegovy promise relief, clinicians Bronwyn Wood and Courtney Nelson argue for a broader approach. Their workshops challenge weight-centric care to foster true silencing through body neutrality and informed prescribing.
Hollywood's shift to GLP-1 drugs like Ozempic has led to leaner figures on the red carpet, but some celebs are facing 'Ozempic neck'—loose skin from fast weight loss. This guide explains the phenomenon, its causes, and strategies to manage it. Understand why skin struggles to keep up with GLP-1-induced changes.
GLP-1 receptor agonists, originally developed for diabetes, are gaining attention for potential benefits in multiple sclerosis (MS) due to their effects on the brain and metabolic health. Expert Afsaneh Shirani, MD, highlighted promising studies at ACTRIMS, including weight loss and minimal relapses, but stressed the need for more rigorous trials. Key challenges like biomarkers, patient selection, and access remain.
New Cochrane research reveals intermittent fasting offers no weight loss advantage over traditional dietary advice or even no intervention at all. Analyzing 22 studies with 1,995 overweight or obese adults, the review highlights similar outcomes across groups. Discover the details and potential benefits beyond the scale.
South Korean chef and broadcaster Lee Soon-sil turned heads in a fitted hanbok on KBS1's Morning Maze, revealing her impressive 30kg weight loss achieved with Wegovy. Her husband Hwang Yoo-sung couldn't hide his admiration, calling her 'so pretty.' This heartfelt TV moment highlights real-world Wegovy success in metabolic health.
In Manhattan medspas and Bushwick fridges, peptides are fueling a quest for the perfect body—from GLP-1 pens vanquishing appetite to experimental vials promising telomere extension. But as biohackers chase the peptide Übermensch, what hidden costs lurk in this shift from treating illness to perfecting the self? Discover the cultural frenzy, market divides, and societal stakes.
